content top

Dilon Technologies’ BSGI/MBI Featu...

Dilon Technologies’ BSGI/MBI Featured in RSNA Presentations.
Breast-Specific Gamma Imaging/Molecular Breast Imaging (BSGI/MBI) is gaining momentum as a standard of care in the diagnostic work up of patients. More than ten BSGI/MBI educational exhibits will be presented at the 2010 Radiological Society of North America (RSNA) annual meeting in Chicago next week. These upcoming presentations, along with others at radiology, surgical, and breast...

Mammotome Nets 510(k)

Mammotome Nets 510(k)
Mammotome, a division of Devicor Medical Products, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Mammotome MI (Molecular Imaging) System, used to conduct minimally invasive, vacuum-assisted breast biopsy with molecular imaging guidance. It is the first device of its kind to receive FDA clearance and it is commercially available to...

Next Entries »